EdgarLookup

Travere Therapeutics, Inc. — SC 13G/A Filings

66 SC 13G/A filings on record

This page lists all SC 13G/A filings submitted to the SEC by Travere Therapeutics, Inc. (TVTX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Travere Therapeutics, Inc. has filed 66 SC 13G/A documents with the SEC since 2014. To view all SEC filings by Travere Therapeutics, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-12G 10-12G/A 10-K 10-K/A 10-Q 10-Q/A 144 3 3/A 305B2 4 4/A 424B1 424B3 424B5 5 8-A12B 8-K 8-K/A ARS CERTNAS CORRESP CT ORDER D DEF 14A DEFA14A DRS DRS/A EFFECT FWP NT 10-K NT 10-Q PRE 14A RW S-1 S-1/A S-3 S-3/A S-3ASR S-3MEF S-8 SC 13D SC 13D/A SC 13G SC 13G/A SC 14F1 SC 14F1/A SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
SC 13G/A 0001172661-24-005319 Nov 14, 2024
SC 13G/A 0001172661-24-004777 Nov 14, 2024
SC 13G/A 0000932471-24-001276 Nov 12, 2024
SC 13G/A 0000932471-24-000711 Nov 4, 2024
SC 13G/A 0001172661-24-001245 Feb 14, 2024
SC 13G/A 0001172661-24-000946 Feb 14, 2024
SC 13G/A SC 13G/A 0001193125-24-034915 Feb 14, 2024
SC 13G/A SCHEDULE 13G/A 0001104659-24-022126 Feb 13, 2024
SC 13G/A TRAVERE THERAPEUTICS, INC. 0000902664-24-001160 Feb 7, 2024
SC 13G/A 0001086364-24-002023 Jan 24, 2024
SC 13G/A 0001306550-23-010082 Oct 6, 2023
SC 13G/A SC 13G/A 0001104659-23-060912 May 15, 2023
SC 13G/A SC 13G/A 0001104659-23-021819 Feb 14, 2023
SC 13G/A SC 13G/A 0001193125-23-038860 Feb 14, 2023
SC 13G/A 0001172661-23-001188 Feb 14, 2023
SC 13G/A 0001172661-23-000857 Feb 14, 2023
SC 13G/A SCHEDULE 13G/A 0001104659-23-017128 Feb 9, 2023
SC 13G/A TRAVERE THERAPEUTICS, INC. 0000902664-23-001338 Feb 9, 2023
SC 13G/A 0001306550-23-007654 Feb 3, 2023
SC 13G/A SC 13G/A 0001193125-22-042020 Feb 14, 2022
SC 13G/A TRAVERE THERAPEUTICS, INC. 0001104659-22-022755 Feb 14, 2022
SC 13G/A SC 13G/A 0001193125-22-040207 Feb 14, 2022
SC 13G/A 0001172661-22-000428 Feb 14, 2022
SC 13G/A TRAVERE THERAPEUTICS, INC. 0000902664-22-001399 Feb 10, 2022
SC 13G/A SCHEDULE 13G/A 0001104659-22-018734 Feb 10, 2022
SC 13G/A 0000834237-22-005508 Feb 3, 2022
SC 13G/A SC 13G/A 0001104659-21-024245 Feb 16, 2021
SC 13G/A SC 13G/A 0001193125-21-044692 Feb 16, 2021
SC 13G/A CONSONANCE CAPITAL MANAGEMENT LP 0001085146-21-000938 Feb 16, 2021
SC 13G/A 0001319244-21-000115 Feb 11, 2021
SC 13G/A SCHEDULE 13G/A 0001104659-21-019252 Feb 10, 2021
SC 13G/A 0000834237-21-005445 Feb 1, 2021
SC 13G/A SC 13G/A 0001193125-20-038267 Feb 14, 2020
SC 13G/A CONSONANCE CAPITAL MANAGEMENT LP 0001085146-20-000796 Feb 14, 2020
SC 13G/A SCHEDULE 13G/A 0000891092-20-001777 Feb 14, 2020
SC 13G/A 0000919574-20-001120 Feb 13, 2020
SC 13G/A SC 13G/A 0001193125-20-034843 Feb 13, 2020
SC 13G/A 0000834237-20-000050 Jan 10, 2020
SC 13G/A SCHEDULE 13G/A 0000891092-19-008367 Aug 12, 2019
SC 13G/A SCHEDULE 13G/A 0000891092-19-001947 Feb 14, 2019
SC 13G/A CONSONANCE CAPITAL MANAGEMENT LP 0001085146-19-000745 Feb 14, 2019
SC 13G/A 0000215457-19-007297 Feb 11, 2019
SC 13G/A SCHEDULE 13G/A 0000891092-18-001356 Feb 14, 2018
SC 13G/A CONSONANCE CAPITAL MANAGEMENT LP 0001085146-18-000755 Feb 14, 2018
SC 13G/A 0000919574-18-001218 Feb 13, 2018
SC 13G/A 13G FINAL ANNUAL AMENDMENT - RTRX 0000053417-18-000059 Feb 5, 2018
SC 13G/A 0000215457-18-002528 Jan 23, 2018
SC 13G/A SCHEDULE 13G/A 0000891092-17-001362 Feb 14, 2017
SC 13G/A CONSONANCE CAPITAL MANAGEMENT LP 0001085146-17-000629 Feb 13, 2017
SC 13G/A 0000919574-17-001194 Feb 10, 2017